Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials
David L Wirta,1 Michael S Korenfeld,2 Shane Foster,3 Robert Smyth-Medina,4 Jason Bacharach,5 Shane R Kannarr,6 Mark J Jaros,7 Charles B Slonim8 1Aesthetic Eye Care Institute & Eye Research Foundation, Newport Beach, CA, USA; 2Comprehensive Eye Care, Ltd., Washington, MO, USA; 3Athens Eye Car...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b902ef01813a410a8ed913930410b88d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!